Mflrig 1208160004405181

Download as pdf or txt
Download as pdf or txt
You are on page 1of 2

MISHTANN FOODS LIMITED

Registered Office: B-905, Empire Business Hub, Opp Shakti Farm, Science City Road, Sola, Ahmedabad- 380 060, Gujarat, India;
Tel: +91 982 462 3116; Fax: N.A.;
E-mail: info@mishtann.com; Website: www.mishtann.com;
Contact Person: Shivangi Digant Shah, Company Secretary and Compliance Officer;
Corporate Identification Number: L15400GJ1981PLC004170

RIGHTS ENTITLEMENT LETTER

Ref.No.: 246393
DP ID - Client ID / Folio No.: 1208160004405181
Sole/First Holder name : SUHAS SURESHBABU
Address: NO 33 BEST CONTY 2 1ST MN RD
BH SAI BABA TEMPLE HESARAGHATT
MN RD CHIKKABETAHALLI BANGALOR
BENGALURU KARNATAKA
KARNATAKA
560097

Dear Shareholder,
ISSUE OF 3,32,12,903 EQUITY SHARES OF FACE VALUE ₹ 1 EACH (“RIGHTS EQUITY SHARES”) OF OUR COMPANY FOR CASH AT A PRICE OF ₹ 15 PER EQUITY SHARE (INCLUDING A SHARE
PREMIUM OF ₹ 14 PER EQUITY SHARE) (THE “ISSUE PRICE”), AGGREGATING TO ₹ 49,81,93,545 ON A RIGHTS BASIS TO THE EXISTING EQUITY SHAREHOLDERS OF OUR COMPANY IN THE
RATIO OF 1 RIGHTS EQUITY SHARE(S) FOR EVERY 31 FULLY PAID-UP EQUITY SHARE(S) HELD BY THE EXISTING EQUITY SHAREHOLDERS ON THE RECORD DATE, THAT IS ON MARCH
20, 2024 (THE “ISSUE”). THE ISSUE PRICE FOR THE RIGHTS EQUITY SHARES IS FIFTEEN TIMES OF THE VALUE OF THE EQUITY SHARES. FOR FURTHER DETAILS, PLEASE REFER TO THE
CHAPTER TITLED “TERMS OF THE ISSUE” ON PAGE 228 OF THE LETTER OF OFFER.
You have been sent this letter and the Abridged Letter of Offer and the Application Form enclosed herewith to comply with the provisions of the Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements)
Regulations, 2018, as amended (“SEBI ICDR Regulations”), and the relevant circulars issued by SEBI from time to time. This letter and the enclosures are solely intended for distribution to, and use by, Eligible Equity Shareholders
as of the Record Date who are located outside the United States, have provided an Indian address to our Company and who are located in jurisdictions where the offer and sale of the Rights Entitlement or Rights Equity Shares is
permitted under laws of such jurisdiction and does not result in and may not be construed as, a public offering in such jurisdictions. This letter does not constitute an offer of, or a solicitation of an offer to purchase, the Rights Equity
Shares in any jurisdiction where offers or solicitations are not permitted by law. For more details, see “Selling Restrictions” on page 223 of the Letter of Offer. If you are not permitted to subscribe to Rights Equity Shares or
are in any doubt as to whether you are permitted to subscribe to Rights Equity Shares, please treat this letter and the enclosures as being sent to you for information purposes only and you may not apply to subscribe
to the Rights Equity Shares. This letter and its enclosures, including any copies thereof, should not be reproduced, transmitted or distributed to any other person.
With reference to above, please find below the details of Equity Shares held by you as on Record Date i.e., Wednesday, March 20, 2024 along with your Rights Entitlements:
Folio Number / DP or Client ID No. of Equity Shares held by you on Record Date being Wednesday, March 20, 2024 No. of Rights Entitlement

1208160004405181 1289 41
Eligible Equity Shareholders can also obtain the details of their respective Rights Entitlements from the website of the Registrar (i.e., https://rights.kfintech.com) by entering their DP ID and Client ID or Folio Number (in case of
Eligible Equity Shareholders holding Equity Shares in physical form as on Record Date) and PAN. The link for the same shall also be available on the website of our Company (i.e., www.mishtann.com).
Payment Terms
₹15 per Rights Equity Share (including premium of ₹14 per Rights Equity Share) shall be payable in full on Application.
Procedure for Application in the Issue
In accordance with Regulation 76 of the SEBI ICDR Regulations, the SEBI ICDR Master Circular and the ASBA Circulars, all Investors desiring to make an Application in this Issue are mandatorily required to use the ASBA
process. Investors should carefully read the provisions applicable to such Applications before making their Application through ASBA. For details see “Terms of the Issue - Process of making an Application in the Issue ” beginning
on page 230 of the Letter of Offer.
Credit of Rights Entitlements in demat accounts of Eligible Equity Shareholders
In accordance with Regulation 77A of the SEBI ICDR Regulations read with the SEBI ICDR Master Circular, the credit of Rights Entitlements and Allotment of Equity Shares shall be made in dematerialised form only.
Prior to the Issue Opening Date, our Company shall credit the Rights Entitlements to (i) the demat accounts of the Eligible Equity Shareholders holding the Equity Shares in dematerialised form; and (ii) a demat suspense escrow
account (namely, “Mishtann Foods Limited”) opened by our Company, for the Eligible Equity Shareholders which would comprise Rights Entitlements relating to (a) Equity Shares held in the account of the IEPF authority; or (b)
the demat accounts of the Eligible Equity Shareholder which are frozen or the Equity Shares which are lying in the unclaimed suspense account (including those pursuant to Regulation 39 of the SEBI LODR Regulations) or details
of which are unavailable with our Company or with the Registrar on the Record Date; or (c) Equity Shares held by Eligible Equity Shareholders holding Equity Shares in physical form as on Record Date where details of demat
accounts are not provided by Eligible Equity Shareholders to our Company or Registrar; or (d) credit of the Rights Entitlements returned/reversed/failed; or (e) the ownership of the Equity Shares currently under dispute, including
any court proceedings, if any; or (f) non-institutional equity shareholders in the United States.
Additionally, our Company will submit the details of the total Rights Entitlements credited to the demat accounts of the Eligible Equity Shareholders and the demat suspense escrow account to the Stock Exchanges after completing
the corporate action. The details of the Rights Entitlements with respect to each Eligible Equity Shareholders can be accessed by such respective Eligible Equity Shareholders on the website of the Registrar after keying in their
respective details along with other security control measures implemented thereat.
Rights Entitlements shall be credited to the respective demat accounts of Eligible Equity Shareholders before the Issue Opening Date only in dematerialised form. Further, if no Application is made by the Eligible Equity
Shareholders of Rights Entitlements on or before Issue Closing Date, such Rights Entitlements shall lapse and shall be extinguished after the Issue Closing Date. No Rights Equity Shares for such lapsed Rights Entitlements will
be credited, even if such Rights Entitlements were purchased from market and purchaser will lose the premium paid to acquire the Rights Entitlements. Persons who are credited the Rights Entitlements are required to make an
Application to apply for Rights Equity Shares offered under Issue for subscribing to the Rights Equity Shares offered under Issue.
If Eligible Equity Shareholders holding Equity Shares in physical form as on Record Date, have not provided the details of their demat accounts to our Company or to the Registrar, they are required to provide their demat account
details to our Company or the Registrar not later than two clear Working Days prior to the Issue Closing Date, to enable the credit of the Rights Entitlements by way of transfer from the demat suspense escrow account to their
respective demat accounts, at least one day before the Issue Closing Date. Such Eligible Equity Shareholders holding shares in physical form can update the details of their respective demat accounts on the website of the Registrar
(i.e. https://rights.kfintech.com). Such Eligible Equity Shareholders can make an Application only after the Rights Entitlements is credited to their respective demat accounts.
Eligible Equity Shareholders are requested to provide relevant details (such as copies of self-attested PAN and client master sheet of demat account etc., details/ records confirming the legal and beneficial ownership of their
respective Equity Shares) to our Company or the Registrar not later than two clear Working Days prior to the Issue Closing Date, i.e., by April 16, 2024 to enable the credit of their Rights Entitlements by way of transfer from
the demat suspense escrow account to their demat account at least one day before the Issue Closing Date, to enable such Eligible Equity Shareholders to make an application in the Issue, and this communication shall serve as an
intimation to such Eligible Equity Shareholders in this regard. Such Eligible Equity Shareholders are also requested to ensure that their demat account, details of which have been provided to our Company or the Registrar is active
to facilitate the aforementioned transfer. For details, please see “Terms of the Issue” on page 228 of the Letter of Offer.
Notice to Holders of Equity Shares in Physical Form
Please note that, in accordance with Regulation 77A of the SEBI ICDR Regulations read with the SEBI ICDR Master Circular, the credit of Rights Entitlements and Allotment of Rights Equity Shares shall be made
in dematerialised form only.
ELIGIBLE EQUITY SHAREHOLDERS, WHO HOLD EQUITY SHARES IN PHYSICAL FORM AS ON RECORD DATE AND WHO HAVE NOT FURNISHED THE DETAILS OF THEIR RESPECTIVE DEMAT
ACCOUNTS TO THE REGISTRAR OR OUR COMPANY AT LEAST TWO WORKING DAYS PRIOR TO THE ISSUE CLOSING DATE, SHALL NOT BE ELIGIBLE TO MAKE AN APPLICATION FOR
RIGHTS EQUITY SHARES AGAINST THEIR RIGHTS ENTITLEMENTS WITH RESPECT TO THE EQUITY SHARES HELD IN PHYSICAL FORM.
Accordingly, Eligible Equity Shareholders holding Equity Shares in physical form as on Record Date and desirous of subscribing to Rights Equity Shares in the Issue are advised to furnish the details of their demat account to
the Registrar or our Company at least two clear Working Days prior to the Issue Closing Date, to enable the credit of their Rights Entitlements in their respective demat accounts at least one day before the Issue Closing Date.
Resident Eligible Equity Shareholders who hold Equity Shares in physical form as on the Record Date will not be allowed to renounce their Rights Entitlements in the Issue. However, such Eligible Equity Shareholders, where
the dematerialized Rights Entitlements are transferred from the suspense escrow demat account to the respective demat accounts within prescribed timelines, can apply for Additional Rights Equity Shares while submitting the
Application through ASBA process.
Access to Issue Materials
Investors can access the Letter of Offer, the Letter of Offer, the Abridged Letter of Offer and the Application Form (provided that the Eligible Equity Shareholder is eligible to subscribe for the Rights Equity Shares under applicable
laws) on the websites of:
(i) our Company at www.mishtann.com;
(ii) the Registrar at https://rights.kfintech.com; and
(iii) the Stock Exchanges at www.bseindia.com and www.msei.in.
Trading of the Rights Entitlements:
The Eligible Equity Shareholders may renounce the Rights Entitlements, credited to their respective demat accounts by trading/selling them on the secondary market platform of the Stock Exchanges through a registered stock-broker
in the same manner as the existing Equity Shares of our Company. In this regard, in terms of provisions of the SEBI ICDR Regulations and the SEBI Master Circular, the Rights Entitlements credited to the respective demat accounts
of the Eligible Equity Shareholders shall be admitted for trading on the the Stock Exchanges under ISIN: INE094S20017 subject to requisite approvals. Prior to the Issue Opening Date, our Company will obtain the approval from
the Stock Exchanges for trading of Rights Entitlements. No assurance can be given regarding the active or sustained On Market Renunciation or the price at which the Rights Entitlements will trade. The details for trading in Rights
Entitlements will be as specified by the Stock Exchanges from time to time. For more details, see “Procedure for Renunciation of Rights Entitlements” on page 241 of the Letter of Offer.
Renunciation of Rights Entitlements
The Issue includes a right exercisable by Eligible Equity Shareholders to renounce the Rights Entitlements credited to their respective demat account either in full or in part.
The renunciation from non-resident Eligible Equity Shareholder(s) to resident Indian(s) and vice versa shall be subject to provisions of FEMA Rules and other circular, directions, or guidelines issued by RBI or the Ministry of
Finance from time to time. However, the facility of renunciation shall not be available to or operate in favour of an Eligible Equity Shareholders being an erstwhile OCB unless the same is in compliance with the FEMA Rules and
other circular, directions, or guidelines issued by RBI or the Ministry of Finance from time to time.
The renunciation of Rights Entitlements credited in your demat account can be made either by sale of such Rights Entitlements, using the secondary market platform of the Stock Exchanges or through an off market transfer.
In accordance with the SEBI Master Circular, the resident Eligible Equity Shareholders, who hold Equity Shares in physical form as on Record Date shall be required to provide their demat account details to our Company or the
Registrar to the Issue for credit of REs not later than two working days prior to Issue Closing Date, such that credit of REs in their demat account takes place at least one day before Issue Closing Date. For more details, see “Terms
of the Issue - Renunciation and Trading of Rights Entitlement on page 241 of the Letter of Offer.
The Rights Entitlements are tradable in dematerialized form only. The market lot for trading of Rights Entitlements is 1 (one) Rights Entitlements.
The On Market Renunciation shall take place only during the Renunciation Period for On Market Renunciation, i.e., from April 02, 2024, to April 12, 2024 (both days inclusive). The Investors holding the Rights Entitlements who
desire to sell their Rights Entitlements will have to do so through their registered stock-brokers by quoting the ISIN: INE094S20017 and indicating the details of the Rights Entitlements they intend to trade. The Investors can place
order for sale of Rights Entitlements only to the extent of Rights Entitlements available in their demat account.
PLEASE NOTE THAT THE RIGHTS ENTITLEMENTS WHICH ARE NEITHER RENOUNCED NOR SUBSCRIBED ON OR BEFORE THE ISSUE CLOSING DATE SHALL LAPSE AND SHALL BE
EXTINGUISHED AFTER THE ISSUE CLOSING DATE.
Fractional Entitlements
The Rights Equity Shares are being offered on a rights basis to Eligible Equity Shareholders in the ratio of 1 Rights Equity Shares for every 31 Equity Shares held on the Record Date. For Equity Shares being offered on a rights
basis under the Issue, if the shareholding of any of the Eligible Equity Shareholders is less than 31 Rights Equity Shares or not in the multiple of 31, the fractional entitlement of such Eligible Equity Shareholders shall be ignored in
the computation of the Rights Entitlement. However, the Eligible Equity Shareholders whose fractional entitlements are being ignored, will be given preferential consideration for the allotment of one additional Equity Share each
if they apply for additional Equity Shares over and above their rights entitlement, if any.
Further, the Eligible Equity Shareholders holding less than 31 Equity Shares shall have ‘zero’ entitlement in the Issue. Such Eligible Equity Shareholders are entitled to apply for additional Equity Shares and will be given preference
in the allotment of one additional Equity Share if, such Eligible Equity Shareholders apply for the additional Equity Shares. However, they cannot renounce the same in favour of third parties and the application forms shall be
non-negotiable. For more details, see “Terms of the Issue - Basis for This Issue and Terms of this Issue - Fractional Entitlements” on page 244 of the Letter of Offer.
Issue Schedule
Issue Opening Date April 02, 2024 Date of Allotment (on or about) April 26, 2024
Last date for receiving requests for Application Form and Rights Entitlement Letter# April 12,2024 Initiation of refunds April 29, 2024
Issue Closing Date* April 16, 2024 Date of credit (on or about) May 06, 2024
Finalising the basis of allotment with the Designated Stock Exchange April 26, 2024 Date of listing (on or about) May 07, 2024
*Our Board may, however, decide to extend the Issue Period as it may determine from time to time but not exceeding 30 days from the Issue Opening Date (inclusive of the Issue Opening Date).
*Investors are advised to ensure that the Application Forms are submitted on or before the Issue Closing Date. Our Company and/or the Registrar to the Issue will not be liable for any loss on account of non-submission of
Application Forms or on before the Issue Closing Date.
#
Eligible Equity Shareholders are requested to ensure that renunciation through off-market transfer is completed in such a manner that the Rights Entitlements are credited to the demat account of the Renouncee(s)on or prior to
the Issue Closing Date.
Please note that if Eligible Equity Shareholders holding Equity Shares in physical form as on Record Date, have not provided the details of their demat accounts to our Company or to the Registrar, they are required to provide their
demat account details to our Company or the Registrar not later than two clear Working Days prior to the Issue Closing Date, i.e., April 12, 2024, to enable the credit of the Rights Entitlements by way of transfer from the demat
suspense escrow account to their respective demat accounts, at least one day before the Issue Closing Date, i.e., April 15, 2024.
Notice to Investors
The distribution of the Letter of Offer, the Abridged Letter of Offer, Application Form and Rights Entitlement Letter and the issue of Rights Entitlement and Rights Equity Shares to persons in certain jurisdictions outside India
may be restricted by legal requirements prevailing in those jurisdictions. Persons into whose possession the Letter of Offer, the Abridged Letter of Offer or Application Form may come are required to inform themselves about and
observe such restrictions.
The Abridged Letter of Offer, the Application Form, the Rights Entitlement Letter and any other material relating to the Issue (collectively, the “Issue Materials”) will be sent/ dispatched only to the Eligible Equity Shareholders who
have provided an Indian address to our Company. In case such Eligible Equity Shareholders have provided their valid e-mail address to our Company, the Issue Materials will be sent only to their valid e-mail address and in case
such Eligible Equity Shareholders have not provided their e-mail address, then the Issue Material will be physically dispatched, on a reasonable effort basis, to the Indian addresses provided by them. Those overseas Shareholders
who do not update our records with their Indian address or the address of their duly authorized representative in India, prior to the date on which we propose to dispatch the Issue Materials, shall not be sent the Issue Materials.
Investors can also access Draft Letter of Offer, the Letter of Offer, the Abridged Letter of Offer and the Application Form from the websites of our Company, the Registrar and the Stock Exchanges. Our Company and the Registrar
will not be liable for non-dispatch of physical copies of Issue Materials, including the Abridged Letter of Offer, the Rights Entitlement Letter and the Application Form, in the event the Issue Materials have been sent on the registered
email addresses of such Eligible Equity Shareholders.
No action has been or will be taken to permit the Issue in any jurisdiction where action would be required for that purpose, except that the Letter of Offer is being filed with Stock Exchanges for observations. In particular, the Rights
Entitlements and the Rights Equity Shares have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”), or the securities laws of any state of the United States and may not be
offered or sold in the United States, except in a transaction not subject to, or exempt from, the registration requirements of the Securities Act and applicable state securities laws. The Rights Entitlements and Rights Equity Shares
referred to in the Letter of Offer are being offered in offshore transactions outside the United States in compliance with Regulation S under the Securities Act and in the United States to “qualified institutional buyers” (as defined
in Rule 144A under the Securities Act) in transactions exempt from the registration requirements under Section 4(a) of the Securities Act. The offering to which the Letter of Offer relates is not, and under no circumstances is to be
construed as, an offering of any Rights Equity Shares or Rights Entitlements for sale in the United States or as a solicitation therein of an offer to buy any of such securities, except in each case to persons in the United States who are
U.S. Qualified Institutional Buyers (“QIBs”). Accordingly, you should not forward or transmit the Letter of Offer in or into the United States at any time. The Letter of Offer, and any other Issue Materials must be treated as sent for
information only and should not be acted upon for subscription to Rights Equity Shares and should not be copied or re-distributed. Accordingly, persons receiving a copy of the Letter of Offer, and any other Issue Materials should
not distribute or send the Letter of Offer or any such documents in or into any jurisdiction where to do so, would or might contravene local securities laws or regulations, or would subject our Company or its affiliates to any filing
or registration requirement (other than in India). If the Letter of Offer or any other Issue Material is received by any person in any such jurisdiction or the United States, they must not seek to subscribe to the Rights Equity Shares.
For more details, see “Restrictions on Foreign Ownership of Indian Securities” beginning on page 254 of the Letter of Offer.
NOTICE TO INVESTORS IN THE UNITED STATES
THE RIGHTS ENTITLEMENTS AND THE RIGHTS EQUITY SHARES HAVE NOT BEEN AND WILL NOT BE REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED,
OR ANY U.S. STATE SECURITIES LAWS AND MAY NOT BE OFFERED, SOLD, RESOLD OR OTHERWISE TRANSFERRED WITHIN THE UNITED STATES OR THE TERRITORIES OR POSSESSIONS
THEREOF, EXCEPT IN A TRANSACTION EXEMPT FROM THE REGISTRATION REQUIREMENTS OF THE SECURITIES ACT. THE RIGHTS ENTITLEMENTS AND RIGHTS EQUITY SHARES
REFERRED TO IN THE LETTER OF OFFER ARE BEING OFFERED IN OFFSHORE TRANSACTIONS OUTSIDE THE UNITED STATES IN COMPLIANCE WITH
REGULATION S UNDER THE SECURITIES ACT AND IN THE UNITED STATES TO “QUALIFIED INSTITUTIONAL BUYERS” (AS DEFINED IN RULE 144A UNDER THE SECURITIES ACT) IN
TRANSACTIONS EXEMPT FROM THE REGISTRATION REQUIREMENTS UNDER SECTION 4(a) OF THE SECURITIES ACT. THE OFFERING TO WHICH THE LETTER OF OFFER RELATES IS
NOT, AND UNDER NO CIRCUMSTANCES IS TO BE CONSTRUED AS, AN OFFERING OF ANY RIGHTS EQUITY SHARES OR RIGHTS ENTITLEMENTS FOR SALE IN THE UNITED STATES OR AS A
SOLICITATION THEREIN OF AN OFFER TO BUY ANY OF SUCH SECURITIES, EXCEPT IN EACH CASE TO PERSONS IN THE UNITED STATES WHO ARE U.S. QIBs. ACCORDINGLY, YOU SHOULD
NOT FORWARD OR TRANSMIT THE LETTER OF OFFER IN OR INTO THE UNITED STATES AT ANY TIME.
Any person who makes an application to acquire Rights Entitlements and the Rights Equity Shares offered in the Issue will be deemed to have declared, represented, warranted and agreed that such person is authorized to acquire
the Rights Entitlements and the Equity Shares in compliance with all applicable laws and regulations prevailing in such person’s jurisdiction and India, without requirement for our Company or our affiliates to make any filing or
registration (other than in India). In addition, each purchaser of Rights Entitlements and the Rights Equity Shares will be deemed to make the representations, warranties, acknowledgments and agreements set forth in “Restrictions
on Foreign Ownership of Indian Securities” beginning on page 254 of the Letter of Offer.
Neither our Company, nor any person acting on behalf of our Company, will accept a subscription or renunciation from any person, or the agent of any person, who appears to be, or who our Company, or any person acting on behalf
of our Company, has reason to believe is, (A) in the United States when the buy order is made (other than persons in the United States who are U.S. QIBs) or (B) outside India or the United States, and not a corporate Shareholder
acquiring the Rights Entitlements or Rights Equity Shares in compliance with laws of such other jurisdiction. Envelopes containing an Application Form should not be postmarked in the United States or otherwise dispatched from
the United States (other than from persons in the United States who are U.S. QIBs) or any other jurisdiction where it would be illegal to make an offer under the Letter of Offer or where any action would be required to be taken
to permit the Issue. Our Company is making the Issue on a rights basis to the Eligible Equity Shareholders and will dispatch the Issue Materials only to Eligible Equity Shareholders (i) who have provided an Indian address to our
Company and (ii) to foreign corporate or institutional Shareholders in Identified Jurisdictions. Any person who acquires Rights Entitlements or Rights Equity Shares will be deemed to have represented, warranted and agreed, by
accepting the delivery of the Letter of Offer, that (i) it is not and that at the time of subscribing for the Rights Equity Shares or the Rights Entitlements, it will not be, in the United States when the buy order is made and (a) is either
in India or (b) is in an Identified Jurisdiction (other than the United States) and a corporate Shareholder acquiring the Rights Entitlements or Rights Equity Shares in compliance with laws of its jurisdiction, or (ii) it is a U.S. QIB
in the United States, and in each case is authorized to acquire the Rights Entitlement and the Rights Equity Shares in compliance with all applicable laws and regulations.
Our Company reserves the right to treat as invalid any Application Form which: (i) appears to our Company or its agents to have been executed in or dispatched from the United States (unless the Application Form is submitted by
a limited number of U.S. QIB in the United States); or (ii) where our Company believes acceptance of such Application Form may infringe applicable legal or regulatory requirements; and our Company shall not be bound to issue
or Allot any Rights Equity Shares in respect of any such Application Form.
Neither the receipt of the Letter of Offer nor any sale of Rights Equity Shares in terms of the Letter of Offer, shall, under any circumstances, create any implication that there has been no change in our Company’s affairs from the
date hereof or the date of such information or that the information contained herein is correct as at any time subsequent to the date of the Letter of Offer or the date of such information. The contents of the Letter of Offer should
not be construed as legal, tax, business, financial or investment advice. Prospective investors may be subject to adverse foreign, state or local tax or legal consequences as a result of the offer of Rights Equity Shares or Rights
Entitlements. As a result, each investor should consult its own counsel, business advisor and tax advisor as to the legal, business, tax and related matters concerning the offer of the Rights Equity Shares or Rights Entitlements.
In addition, our Company or its affiliates are not making any representation to any offeree or purchaser of the Rights Equity Shares regarding the legality of an investment in the Rights Entitlements or the Rights Equity Shares by
such offeree or purchaser under any applicable laws or regulations.
Investors are advised to make their independent investigations and ensure that the number of Rights Equity Shares applied for do not exceed the applicable limits under laws or regulations. The Rights Entitlements and the Rights
Equity Shares have not been approved or disapproved by any regulatory authority, nor has any regulatory authority passed upon or endorsed the merits of the offering of the Rights Entitlements, the Rights Equity Shares or the
accuracy or adequacy of the Letter of Offer. Any representation to the contrary is a criminal offence in certain jurisdictions. The Issue Materials are supplied to you solely for your information and may not be reproduced, redistributed
or passed on, directly or indirectly, to any other person or published, in whole or in part, for any purpose.
In case of any queries, you may contact the Company, or the Registrar to the Issue.
COMPANY REGISTRAR TO THE ISSUE

MISHTANN FOODS LIMITED KFIN TECHNOLOGIES LIMITED


Registered Office: B-905, Empire Business Hub, Opp Shakti Farm, Selenium Tower-B, Plot 31 & 32, Gachibowli, Financial District,
Science City Road, Sola, Ahmedabad- 380 060, Gujarat, India; Nanakramguda, Serilingampally, Hyderabad – 500 032, Telangana, India.
Tel: +91 982 462 3116; Fax: N.A.; Telephone: +91 406 716 2222 Toll-Free Number: 1800 309 4001
E-mail: info@mishtann.com; Email: mishtann.rights@kfintech.com Website: www.kfintech.com
Website: www.mishtann.com; Investor grievance e-mail: einward.ris@kfintech.com
Contact Person: Shivangi Digant Shah, Company Secretary and Compliance Officer; Contact Person: M Murali Krishna
Corporate Identification Number: L15400GJ1981PLC004170 SEBI Registration No.: INR000000221
Note: All capitalized terms, unless defined herein, shall have the meaning ascribed to them in the Letter of Offer.
For MISHTANN FOODS LIMITED

Sd/-
Shivangi Digant Shah
Company Secretary and Compliance Officer

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy